ARTICLE | Company News
Axaron, Lion bioscience deal
July 10, 2006 7:00 AM UTC
German investor Dietmar Hopp plans to form a new company specializing in CNS diseases by combining LIO and Axaron. The newco will combine LIO's listing and cash with Axaron's AX200, a neuroprotectant...